OClawVPS.com
Qvanteq
Edit

Qvanteq

http://www.qvanteq.com/
Last activity: 24.02.2023
Active
Categories: FastHardwareITMedTechTechnology
Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s medical devices and vascular stents.

Qvanteq’s Qstent technology stands for reduced thrombus formation and fast healing.

Qvanteq AG was founded in early 2009 and is held by private investors. Qvanteq is ISO 13485 certified. Qvanteq is a spin-off company from the Swiss Federal Institute of Technology (ETH) Zurich. The company was awarded with the CTI start-up label in 2012.
Mentions
15
Location: Switzerland, Zurich
Total raised: $4.36M
Founded date: 2009

Investors 3

Funding Rounds 1

DateSeriesAmountInvestors
12.02.2013Series B$4.36M-

Mentions in press and media 15

DateTitleDescription
08.07.2015Schweizer Startups wollen China erobernSchweizer Startups wollen China erobern 08.07.2015 14:00, Nicolas Bopp linkedIn facebook twitter instagram youtube --> Nach der erfolgreichen ersten Ausgabe des venture leaders China Programms 2014 in Peking und Shanghai, steht nun die S...
08.07.2015Die venture leaders China stehen fest
22.04.2015Red Herring announces European winners
10.04.2015Twelve Swiss Start-ups Selected for RedHerring Europe
16.12.2014IMD announces Start-up Competition Winners
25.11.2014Swiss coronary stent company Qvanteq enrolled first patient in clinical study
03.09.2014CTI Swiss Medtech Award 2014: Using ultra sound instead of catheters
16.01.2014Application open for venture leaders
12.02.2013Qvanteq closes series B financing round of CHF4 million
07.12.2012More start-ups than ever at the Swiss Venture Day
Show more

Reviews 0

Sign up to leave a review

Sign up Log In